AG-13958
S2211
Product group Chemicals
Overview
- SupplierSelleck Chemicals
- Product NameAG-13958
- Delivery Days Customer9
- CertificationResearch Use Only
- Scientific DescriptionAG-13958 (AG-013958), a VEGFR tyrosine kinase inhibitor, is in clinical development with ST administration for treatment of choroidal neovascularization associated with age–related macular degeneration (AMD).
- UNSPSC12352200